- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06042439
AM vs PM træningstræning
Effekter af AM vs. PM træningstræning på blodtryk og vaskulær sundhed hos postmenopausale kvinder med hypertension
The treatment of high blood pressure, or hypertension, is multifaceted and can include pharmacological therapies (i.e., medications) and lifestyle modifications such as physical activity. Chronotherapy, which describes timing of a treatment with the body's daily rhythms, has recently been used with hypertension medications and has been shown to be effective at lowering blood pressure and reducing the risk of cardiovascular disease events. Specifically, taking medications in the evening was shown to be more effective than morning medication routines. Little information is available about the effectiveness of chronotherapy combined with exercise (i.e., planned physical activity) interventions in older adults with hypertension. The purpose of this study is to examine how exercise training performed in the morning and early evening affects blood pressure and other measures of blood vessel health in postmenopausal females with hypertension.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Blood pressure has an internal rhythm associated with the 24-hr clock. Nocturnal blood pressure (BP) is a key contributor to cardiovascular health and may be improved by exercise. Moreover, the time of day of the exercise may be a key factor. This study aims to evaluate the effects of morning and evening exercise training on BP and other measures of vascular function in older females with hypertension.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Katharine Currie, PhD
- Telefonnummer: 517-432-4073
- E-mail: curriek4@msu.edu
Undersøgelse Kontakt Backup
- Navn: Jill Slade, PhD
- Telefonnummer: 5178843351
- E-mail: jslade@msu.edu
Studiesteder
-
-
Michigan
-
East Lansing, Michigan, Forenede Stater, 48824
- Rekruttering
- Michigan State University
-
Kontakt:
- Jill Slade, PhD
- Telefonnummer: 517-884-3351
- E-mail: jslade@msu.edu
-
Kontakt:
- Katharine Currie, PhD
- Telefonnummer: 517-432-4073
- E-mail: curriek4@msu.edu
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Systolic BP equal to or greater than 130 mmHg without BP medication or greater than 120 mmHg with medication and diastolic blood pressure equal to and greater than 80 mmHg
- 55-80 years old
- Post-menopausal female
- Able to walk without assistance
Exclusion Criteria:
- Habitually physically active defined as 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic physical activity per week
- Overt pulmonary disease/condition as follows: chronic bronchitis, chronic obstructive pulmonary disease, emphysema, or pulmonary hypertension
- Cardiometabolic disease/condition as follows: diabetes, heart failure, peripheral arterial disease, stroke, coronary artery disease, renal disease, secondary hypertension, chronic venous insufficiency or deep vein thrombosis within last 6 months
- Cancer within last 5 years
- Body mass index >39 kg/m2
- Current smoking or vape
- Evening shift work
- uncontrolled thyroid disorder
- 2 or more falls in the last year
- Anemia within 3 months of enrollment
- Parkinson's disease
- Dementia
- Unstable angina
- Acute pulmonary embolus or infarction
- Acute myocarditis or pericarditis
- Acute aortic dissection
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Morning (AM)
Exercise starting before 10:01 AM |
handgrip and treadmill walking 4 days per week handgrip and treadmill walking 4 days per week |
|
Eksperimentel: Evening (PM)
Exercise starting after 3:59 PM |
handgrip and treadmill walking 4 days per week handgrip and treadmill walking 4 days per week |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Nocturnal systolic blood pressure (BP)
Tidsramme: 6 weeks
|
Change in systolic nocturnal BP (Pre-training - Post-training) |
6 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Endothelial function
Tidsramme: 6 weeks
|
Change in flow mediated dilation of the brachial artery (Post-training - Pre-training) |
6 weeks
|
|
Microvascular function
Tidsramme: 6 weeks
|
Change in rapid onset vasodilation of the popliteal artery |
6 weeks
|
|
Ambulatory blood pressure
Tidsramme: 6 weeks
|
Change in systolic and diastolic BPs over a 24-hr period (Pre-training - Post-training) |
6 weeks
|
|
Arterial stiffness
Tidsramme: 6 weeks
|
Change in carotid femoral pulse wave velocity (Pre-training - Post-training) |
6 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- R01HL164575-Study3
- 1R01HL164575-01A1 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .